A. David Rodrigues

3.7k total citations
68 papers, 3.0k citations indexed

About

A. David Rodrigues is a scholar working on Pharmacology, Oncology and Biochemistry. According to data from OpenAlex, A. David Rodrigues has authored 68 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 25 papers in Oncology and 14 papers in Biochemistry. Recurrent topics in A. David Rodrigues's work include Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (24 papers) and Inflammatory mediators and NSAID effects (9 papers). A. David Rodrigues is often cited by papers focused on Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (24 papers) and Inflammatory mediators and NSAID effects (9 papers). A. David Rodrigues collaborates with scholars based in United States, United Kingdom and Brazil. A. David Rodrigues's co-authors include Magang Shou, Gondi Kumar, Alex Buko, Jon F. Denissen, Thomas H. Rushmore, Costas Ioannides, Wenying Li, Cuyue Tang, Ellen Roberts and Jorge Goldstein and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Analytical Biochemistry.

In The Last Decade

A. David Rodrigues

68 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. David Rodrigues United States 33 1.8k 1.1k 619 406 362 68 3.0k
Larry C. Wienkers United States 33 2.6k 1.4× 1.2k 1.1× 947 1.5× 551 1.4× 347 1.0× 79 3.9k
Robert L. Walsky United States 25 1.8k 1.0× 927 0.8× 666 1.1× 318 0.8× 279 0.8× 35 2.7k
Jorge Goldstein United States 34 2.2k 1.2× 1.1k 1.0× 1.0k 1.7× 444 1.1× 468 1.3× 88 4.6k
Mark VandenBranden United States 24 2.4k 1.3× 1.3k 1.2× 615 1.0× 361 0.9× 492 1.4× 28 3.1k
Theunis C. Goosen United States 30 1.8k 1.0× 1.2k 1.1× 756 1.2× 246 0.6× 514 1.4× 62 3.0k
Norie Murayama Japan 39 3.1k 1.7× 1.6k 1.5× 1.2k 2.0× 461 1.1× 448 1.2× 235 5.0k
Cosette J. Serabjit‐Singh United States 24 1.2k 0.7× 1.3k 1.1× 883 1.4× 263 0.6× 463 1.3× 40 3.1k
Richard Weaver United Kingdom 36 1.7k 0.9× 1.2k 1.1× 1.2k 1.9× 329 0.8× 375 1.0× 86 3.9k
Eva Anzenbacherová Czechia 27 1.5k 0.8× 795 0.7× 1.5k 2.4× 398 1.0× 260 0.7× 98 3.6k
Michael Sinz United States 29 1.6k 0.9× 1.1k 0.9× 636 1.0× 201 0.5× 394 1.1× 72 2.8k

Countries citing papers authored by A. David Rodrigues

Since Specialization
Citations

This map shows the geographic impact of A. David Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. David Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. David Rodrigues more than expected).

Fields of papers citing papers by A. David Rodrigues

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. David Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. David Rodrigues. The network helps show where A. David Rodrigues may publish in the future.

Co-authorship network of co-authors of A. David Rodrigues

This figure shows the co-authorship network connecting the top 25 collaborators of A. David Rodrigues. A scholar is included among the top collaborators of A. David Rodrigues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. David Rodrigues. A. David Rodrigues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Min Woo, Lea M. Hürlimann, Joshua A. Lees, et al.. (2025). Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1. Journal of Biological Chemistry. 301(5). 108484–108484. 2 indexed citations
2.
Mathialagan, Sumathy, Yi‐An Bi, Chester Costales, et al.. (2020). Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7). Biochemical Pharmacology. 174. 113829–113829. 31 indexed citations
3.
Bi, Yi‐An, Chester Costales, Sumathy Mathialagan, et al.. (2019). Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 370(1). 72–83. 66 indexed citations
4.
Bi, Yi‐An, Sumathy Mathialagan, Laurie Tylaska, et al.. (2018). Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug. Journal of Pharmacology and Experimental Therapeutics. 364(3). 390–398. 32 indexed citations
5.
Bi, Yi‐An, Renato J. Scialis, Sarah Lazzaro, et al.. (2017). Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. The AAPS Journal. 19(3). 787–796. 39 indexed citations
6.
Shen, Hong, Yurong Lai, & A. David Rodrigues. (2016). Organic Anion Transporter 2: An Enigmatic Human Solute Carrier. Drug Metabolism and Disposition. 45(2). 228–236. 68 indexed citations
7.
Rodrigues, A. David, Simone A. Teixeira, António G. Soares, et al.. (2016). Hydrogen sulfide donors alleviate itch secondary to the activation of type-2 protease activated receptors (PAR-2) in mice. Pharmacological Research. 113(Pt A). 686–694. 16 indexed citations
8.
Jenkins, S. M., Tatyana Zvyaga, Andrew J. Wagner, et al.. (2011). Studies to Further Investigate the Inhibition of Human Liver Microsomal CYP2C8 by the Acyl-β-Glucuronide of Gemfibrozil. Drug Metabolism and Disposition. 39(12). 2421–2430. 25 indexed citations
9.
Gan, Jinping, Weiqi Chen, Hong Shen, et al.. (2010). Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism. British Journal of Clinical Pharmacology. 70(6). 870–880. 34 indexed citations
10.
Chang, Shu‐Ying, Wenying Li, Sarah C. Traeger, et al.. (2008). Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro. Drug Metabolism and Disposition. 36(12). 2513–2522. 53 indexed citations
11.
Ferreira, Marcus Castro, et al.. (2004). New method for evaluation of cutaneous sensibility in diabetic feet: preliminary report. SHILAP Revista de lepidopterología. 59(5). 286–290. 20 indexed citations
12.
Lü, Ping, Michael Schrag, Donald E. Slaughter, et al.. (2003). MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR. Drug Metabolism and Disposition. 31(11). 1352–1360. 86 indexed citations
13.
Rodrigues, A. David. (1999). Discussion. Biochemical Pharmacology. 57(5). 465–480. 308 indexed citations
14.
Kumar, Gondi, et al.. (1997). Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001).. PubMed. 25(1). 110–5. 17 indexed citations
15.
Kempf, Dale J., Akhteruzzaman Molla, Kennan C. Marsh, et al.. (1997). Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease. Bioorganic & Medicinal Chemistry Letters. 7(6). 699–704. 4 indexed citations
16.
Rodrigues, A. David, Michael Kukulka, J L Ferrero, & John R. Cashman. (1995). In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation.. Drug Metabolism and Disposition. 23(10). 1143–1152. 16 indexed citations
17.
Gettings, S.D., Colleen B. Brewer, William M. Pierce, et al.. (1990). Enhanced decomposition of oxyferrous cytochrome P450CIA1 (P450cam) by the chemopreventive agent 3-t-butyl-4-hydroxyanisole. Archives of Biochemistry and Biophysics. 276(2). 500–509. 3 indexed citations
18.
Lewis, D. F. V., A. David Rodrigues, Costas Ioannides, & D. V. Parke. (1989). Adverse reactions of imidazole antifungal agents: Computer graphic studies of cytochrome P‐450 interactions. Journal of Biochemical Toxicology. 4(4). 231–234. 11 indexed citations
19.
Ayrton, Andrew D., E. J. Williams, A. David Rodrigues, Costas Ioannides, & Rheeda L. Walker. (1989). The food pyrolysis product IQ enhances its own activation. Mutagenesis. 4(3). 205–207. 8 indexed citations
20.
Rodrigues, A. David, G. Gordon Gibson, Costas Ioannides, & D. V. Parke. (1987). Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochemical Pharmacology. 36(24). 4277–4281. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry C. Wienkers Breakdown of academic impact, for papers by Robert L. Walsky Breakdown of academic impact, for papers by Jorge Goldstein Breakdown of academic impact, for papers by Mark VandenBranden Breakdown of academic impact, for papers by Theunis C. Goosen Breakdown of academic impact, for papers by Norie Murayama Breakdown of academic impact, for papers by Cosette J. Serabjit‐Singh Breakdown of academic impact, for papers by Richard Weaver Breakdown of academic impact, for papers by Eva Anzenbacherová Breakdown of academic impact, for papers by Michael Sinz
Rankless by CCL
2026